Polyrizon Ltd. Ordinary Shares

NASDAQ:PLRZ USA Biotechnology
Market Cap
$14.17 Million
Market Cap Rank
#27727 Global
#9273 in USA
Share Price
$13.60
Change (1 day)
-4.23%
52-Week Range
$0.00 - $15.99
All Time High
$15.99
About

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nas… Read more

Polyrizon Ltd. Ordinary Shares (PLRZ) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: -0.099x

Based on the latest financial reports, Polyrizon Ltd. Ordinary Shares (PLRZ) has a cash flow conversion efficiency ratio of -0.099x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.82 Million) by net assets ($18.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Polyrizon Ltd. Ordinary Shares - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how Polyrizon Ltd. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Polyrizon Ltd. Ordinary Shares Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Polyrizon Ltd. Ordinary Shares ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Polyrizon Ltd. Ordinary Shares (2020–2024)

The table below shows the annual cash flow conversion efficiency of Polyrizon Ltd. Ordinary Shares from 2020 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $5.29 Million $-1.15 Million -0.217x -107.72%
2023-12-31 $-191.00K $-537.00K 2.812x +61.94%
2022-12-31 $-652.00K $-1.13 Million 1.736x -98.94%
2021-12-31 $-3.00K $-492.00K 164.000x +3694.52%
2020-12-31 $16.00K $-73.00K -4.563x --